ភាគហ៊ុនកំពូលៗបានឡើងដល់កម្រិតខ្ពស់ថ្មី ខណៈដែលភាគហ៊ុនផលិតស៊ុត និងជីវបច្ចេកវិទ្យាលើសពីពិន្ទុទិញ

អ្នកផលិតស៊ុត អាហារកាល់ឡៃ (កាឡៃ) broke solidly into its buy zone Friday while biotech ម៉ាន់ខេន (MNKD) is near the top of its buy zone. Both stocks hit ខ្ពស់ថ្មី this week in spite of the stock market’s downturn.




X



The largest U.S. egg producer continues to record strong growth despite a bird flu outbreak that has decimated chicken flocks in 2022. The reduced supply has sent egg prices skyrocketing, fueling a recovery in earnings and sales growth, according to analysts.

Top Stocks: Reduced Supply Bolsters Egg Profits

Cal-Maine gained 1.6% in Friday’s holiday-thinned ទីផ្សារ. Volume was down 30%  ahead of the three-day weekend. Shares broke out Tuesday from a consolidation with a 62.74 ចំណុចទិញ, យោង​ទៅ​តាម ផ្សារស្មីត analysis. They moved solidly into their buy zone Friday.

Earnings are due out next week, with consensus for a profit of $4.30 per share, up from 2 cents last year.

On Sept. 27, the Mississippi-based egg producer reported Q1 fiscal 2023 results, topping Wall Street’s high expectations. The company has posted five consecutive quarters of accelerating earnings growth.

Cal-Maine stock holds IBD’s highest ranking in the Foods-Meat Products industry group. Shares have a perfect 99 ការវាយតម្លៃសមាសធាតុ. The 95 Relative Strength Rating is also impressive. This metric is an exclusive ការត្រួតពិនិត្យភាគហ៊ុន IBD gauge for share price movement, with a 1 to 99 score. The EPS Rating is 78.

Cal-Maine competitors include Mexico-based Industrias Bachoco (ខ្ញុំកំពុងទៅ), កសិដ្ឋានសំខាន់ (វីអ៊ីធី) និង ធម្មយាត្រា មោទនភាព (គណបក្សប្រជាជន).

Inhalable-Drug Maker Nears Buy Signal

Source: https://www.investors.com/stock-lists/new-highs/top-stocks-egg-producer-and-biotech-hit-new-highs/?src=A00220&yptr=yahoo